KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Gross Margin (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Gross Margin for 4 consecutive years, with 89.14% as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Gross Margin rose 8969.0% year-over-year to 89.14%, compared with a TTM value of 104.87% through Sep 2023, down 11959.0%, and an annual FY2022 reading of 47.46%, down 5036.0% over the prior year.
  • Gross Margin was 89.14% for Q3 2023 at Ginkgo Bioworks Holdings, up from 113.83% in the prior quarter.
  • Across five years, Gross Margin topped out at 89.14% in Q3 2023 and bottomed at 302.92% in Q4 2022.
  • Average Gross Margin over 4 years is 22.3%, with a median of 2.02% recorded in 2022.
  • The sharpest move saw Gross Margin tumbled -34356bps in 2022, then surged 8969bps in 2023.
  • Year by year, Gross Margin stood at 86.7% in 2020, then plummeted by -53bps to 40.63% in 2021, then tumbled by -845bps to 302.92% in 2022, then soared by 129bps to 89.14% in 2023.
  • Business Quant data shows Gross Margin for DNA at 89.14% in Q3 2023, 113.83% in Q2 2023, and 12.03% in Q1 2023.